Dean J. Conterato
Experienced in Teratocarcinosarcoma

Dr. Dean J. Conterato

Radiation Oncology
801 S Milwaukee Ave, 
Libertyville, IL 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Offers Telehealth
Experienced in Teratocarcinosarcoma
801 S Milwaukee Ave, 
Libertyville, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Dean Conterato is a Radiation Oncologist in Libertyville, Illinois. Dr. Conterato is rated as an Experienced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Posterior Fossa Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Anal Cancer.

His clinical research consists of participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Rush University Medical Center, MD
Residency
Rush Presbyterian St. Luke's Medical Center, Radiation Oncology
Specialties
Radiation Oncology
Licenses
Radiology in IL
Board Certifications
American Board Of Radiology, Radiation Oncology
Hospital Affiliations
Alexian Brothers Medical Center 1
St Alexius Medical Center
Advocate Condell Medical Center
Adventist Hinsdale Hospital
Advocate Good Samaritan Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Radiation Oncology Consultants, Ltd
801 S Milwaukee Ave, Libertyville, IL 60048
Other Locations
Radiation Oncology Consultants
1 Salt Creek Ln, Hinsdale, IL 60521
Radiation Oncology Consultants
1555 N Barrington Rd, Ste 1400, Hoffman Estates, IL 60169

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast Conserving Therapy
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast Conserving Therapy
Enrollment Status: Recruiting
Publish Date: September 19, 2024
Intervention Type: Device, Other
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
RT CHARM: Phase III Randomized Trial of Hypofractionated Post Mastectomy Radiation With Breast Reconstruction
Enrollment Status: Active_not_recruiting
Publish Date: October 08, 2025
Intervention Type: Other, Radiation
Study Phase: Phase 3
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Radiation, Drug
Study Phase: Phase 3
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 11, 2025
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
View 6 Less Clinical Trials
Similar Doctors
Advanced in Teratocarcinosarcoma
Dr. Tarita O. Thomas
Radiation Oncology
Advanced in Teratocarcinosarcoma
Dr. Tarita O. Thomas
Radiation Oncology
251 E Huron St Ste LC-178, Galter Pavilion, 
Chicago, IL 
 (31.6 miles away)
312-926-2520
Experience:
18+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Tarita Thomas is a Radiation Oncologist in Chicago, Illinois. Dr. Thomas has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. Her top areas of expertise are Breast Cancer, Anal Cancer, Pleuropulmonary Blastoma, Pancreatic Cancer, and Pancreaticoduodenectomy.

Bharat B. Mittal
Advanced in Teratocarcinosarcoma
Dr. Bharat B. Mittal
Radiation Oncology
Advanced in Teratocarcinosarcoma
Dr. Bharat B. Mittal
Radiation Oncology
251 E Huron St Ste LC-178, Galter Pavilion, 
Chicago, IL 
 (31.6 miles away)
312-926-2520
Experience:
50+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Bharat Mittal is a Radiation Oncologist in Chicago, Illinois. Dr. Mittal has been practicing medicine for over 50 years and is rated as an Advanced provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Laryngeal Cancer, Mycosis Fungoides, Tongue Cancer, and Olfactory Neuroblastoma.

Experienced in Teratocarcinosarcoma
Dr. Nikhil P. Joshi
Radiation Oncology
Experienced in Teratocarcinosarcoma
Dr. Nikhil P. Joshi
Radiation Oncology

Rush University Medical Group

1700 W Van Buren St, 
Chicago, IL 
 (31.2 miles away)
312-563-2875
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Nikhil Joshi is a Radiation Oncologist in Chicago, Illinois. Dr. Joshi is rated as a Distinguished provider by MediFind in the treatment of Teratocarcinosarcoma. His top areas of expertise are Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, and Squamous Cell Skin Carcinoma. Dr. Joshi is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Conterato's expertise for a condition
ConditionClose
    View All 22 Advanced Conditions
    View All 67 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile